Chromoblastomycosis

被引:60
作者
Krzysciak, Pawel M. [1 ]
Pindycka-Piaszczynska, Malgorzata [2 ]
Piaszczynski, Michal [3 ]
机构
[1] Jagiellonian Univ, Coll Med, Chair Microbiol, Dept Mycol, Krakow, Poland
[2] Med Univ Silesia, Chair & Clin Dept Internal Dis Dermatol & Allergo, Katowice, Poland
[3] Med Univ Silesia, Dept Gen Vasc & Transplant Surg, Katowice, Poland
来源
POSTEPY DERMATOLOGII I ALERGOLOGII | 2014年 / 31卷 / 05期
关键词
diagnosis; epidemiology; Fonsecaea pedrosoi; mycoses; treatment; SQUAMOUS-CELL CARCINOMA; FONSECAEA-PEDROSOI; PHIALOPHORA-VERRUCOSA; MOLECULAR PHYLOGENETICS; FUNGAL-INFECTION; LIQUID-NITROGEN; NITRIC-OXIDE; CHROMOMYCOSIS; ITRACONAZOLE; PHEOHYPHOMYCOSIS;
D O I
10.5114/pdia.2014.40949
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Chromoblastomycosis is a chronic fungal infection of the skin and subcutaneous tissue. The infection usually results from a traumatic injury and inoculation of microorganism from a specific group of dematiaceous fungi (usually Fonsecaea pedrosoi, Phialophora verrucosa, Cladophialophora carrionii). In the tissues fungi produce characteristic sclerotic cells or muriform cells. Dermal lesions can range from small nodules to large papillary-like eruptions. The disease has been described worldwide but the prevalence is higher in rural populations in countries with a tropical or subtropical climate, such as Madagascar in Africa and Brazil in South America. Diagnostic techniques are based on direct examination, culture and histopathology. Despite a variety of treatment modalities, which include long courses of antifungals, surgical excision and destructive physical therapies, the disease remains one of the most difficult deep mycotic infections to eradicate.
引用
收藏
页码:310 / 321
页数:12
相关论文
共 127 条
[1]   Specific oligonucleotide primers for identification of Cladophialophora carrionii, a causative agent of chromoblastomycosis [J].
Abliz, P ;
Fukushima, K ;
Takizawa, K ;
Nishimura, K .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (01) :404-407
[2]   Identification of pathogenic dematiaceous fungi and related taxa based on large subunit ribosomal DNA D1/D2 domain sequence analysis [J].
Abliz, P ;
Fukushima, K ;
Takizawa, K ;
Nishimura, K .
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2004, 40 (01) :41-49
[3]   EXPERIMENTAL MURINE CHROMOMYCOSIS MIMICKING CHRONIC PROGRESSIVE HUMAN-DISEASE [J].
AHRENS, J ;
GRAYBILL, JR ;
ABISHAWL, A ;
TIO, FO ;
RINALDI, MG .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1989, 40 (06) :651-658
[4]  
Ajello L, 1981, JPN J MED MYCOL, V22, P1, DOI DOI 10.3314/jjmm1960.22.1
[5]  
ALHEDAITHY SSA, 1988, APMIS, V96, P94
[6]   Chromoblastomycosis: clinical presentation and management [J].
Ameen, M. .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2009, 34 (08) :849-854
[7]   Managing chromoblastomycosis [J].
Ameen, Mahreen .
TROPICAL DOCTOR, 2010, 40 (02) :65-67
[8]   Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents [J].
Andrade, TS ;
Castro, LGM ;
Nunes, RS ;
Gimenes, VMF ;
Cury, AE .
MYCOSES, 2004, 47 (5-6) :216-221
[9]   Auricular chromoblastomycosis caused by Rhinocladiella aquaspersa [J].
Arango, M ;
Jaramillo, C ;
Cortes, A ;
Restrepo, A .
MEDICAL MYCOLOGY, 1998, 36 (01) :43-45
[10]   Chromoblastomycosis - A clinical and mycological study of 71 cases from Sri Lanka [J].
Attapattu, MC .
MYCOPATHOLOGIA, 1997, 137 (03) :145-151